← Leaderboards
Stefani Spranger
University Of Chicago
$2,780,537
Attributed
$2,780,537
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $906.4K · FY2016–25$1M$750K$500K$250K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,780,537 · 4
By mechanism
R37$1,442,174 · 1
R00$747,000 · 1
U54$444,255 · 1
K99$147,108 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Chicago
Same institution · by research overlap
- Thomas F Gajewski$23,743,716
- Nicolas Chevrier$5,887,087
- Randy F. Sweis$850,676
- Justin P. Kline$3,560,218
- Benjamin Derman$659,279
Others in their field
Top investigators on “Neoplastic Cell”
- David Heimbrook · Leidos Biomedical Research, Inc.$139,710,838
- Gregory H Reaman · National Childhood Cancer Foundation$31,993,642
- Bruce W Stillman · Cold Spring Harbor Laboratory$25,455,900
- Ralph Parchment · Leidos Biomedical Research, Inc.$25,266,647
- Andrea Califano · Columbia University Health Sciences$22,374,316
- Wendell A Lim · University Of California, San Francisco$22,334,734
Research focus
Neoplastic CellMelanomaInsightDendritic CellsT-LymphocyteMouse ModelTumorImmunotherapyMediatingImmuneMolecularNon-Small-Cell Lung CarcinomaResponseSiteMalignant Neoplasm Of LungT-Cell ActivationImmune ResponseCancer TypeMalignant NeoplasmsImmunologicsImmunityPreventResistanceT Cell Response
Grant awards (9)
Understanding the induction of T cell dysfunction in the context of lung cancer$462,141
R37 · FY2025 · CA · contact PI
Project 2: Deciphering the Dynamic Evolution of the Tumor-Immune Interface$444,255
U54 · FY2025 · CA · contact PI
Understanding the induction of T cell dysfunction in the context of lung cancer$503,480
R37 · FY2024 · CA · contact PI
Understanding the induction of T cell dysfunction in the context of lung cancer$476,553
R37 · FY2023 · CA · contact PI
Tumor-intrinsic oncogenic alterations and evasion of anti-tumor immunity$249,000
R00 · FY2019 · CA · contact PI
Tumor-intrinsic oncogenic alterations and evasion of anti-tumor immunity$249,000
R00 · FY2018 · CA · contact PI
Tumor-intrinsic oncogenic alterations and evasion of anti-tumor immunity$249,000
R00 · FY2017 · CA · contact PI
Tumor-intrinsic oncogenic alterations and evasion of anti-tumor immunity$35,418
K99 · FY2017 · CA · contact PI
Tumor-intrinsic oncogenic alterations and evasion of anti-tumor immunity$111,690
K99 · FY2016 · CA · contact PI